JPRN-UMIN000048787已完成未知
Optimal dose of long-acting insulin analogue for withdrawal of artificial pancreas after hepatectomy -pilot study- - Optimal dose of long-acting insulin analogue for withdrawal of artificial pancreas after hepatectomy -pilot study
Okayama Saiseikai General Hospital0 个研究点目标入组 27 人开始时间: 2022年8月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 55years-old 至 82years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cases of withdrawal from artificial pancreas
研究者
相似试验
已完成
不适用
Insulin dosing for fat and protein in people with Type 1 Diabetes using insulin injections.Diet and Nutrition - Other diet and nutrition disordersMetabolic and Endocrine - DiabetesType 1 DiabetesACTRN12618002030257Diabetes Australia27
已完成
不适用
Evaluation of long-acting insulin dose corresponding to lixisenatide dose in combination therapy of insulin and lixisenatideType 2 diabetes mellitusJPRN-UMIN000012024Kitano Hospital, The Tazuke Kofukai Medical Research Institute40
已完成
不适用
What is the optimal dose of insulin for the protein content of a meal in individuals with type 1 diabetes mellitus using intensive insulin therapyType 1 Diabetes MellitusACTRN12616000222448Hunter Medical Research Institute32
未知
不适用
Investigation optimal dosing of insulin detemir after switching from other basal insulin by using CGM systemDiabetesJPRN-UMIN000002267Tokyo Women's Medical University20
已完成
不适用
Combined use of long-acting insulin analogue, GLP-1 receptor agonist, and sulfonylurea in type 2 diabetestype 2 diabetes mellitusJPRN-UMIN000017912Shiraiwa Medical Clinic70